Volume 8, Number 11—November 2002
        
THEME ISSUE
            
Tuberculosis Genotyping
    Tuberculosis Genotyping Network, United States
Statewide Molecular Epidemiology of Mycobacterium tuberculosis Transmission in a Moderate- to Low-Incidence State: Are Contact Investigations Enough?
Table 4
Comparison of selected risk-group characteristics of 114 recent tuberculosis (TB) patients by method of source patient identification
| Characteristic | Total recent TB patients (n=114) (%) | Source patient identified by routine contact investigation (n=72) (%) | Source patient identified by cluster investigation (n=42) (%) | p value | 
|---|---|---|---|---|
| Residence | ||||
| Baltimore city | 56 (49.0) | 33 (45.8) | 23 (54.8) | 0.38 | 
| Other state jurisdictions | 58 (51.0) | 39 (54.2) | 19 (45.2) | |
| Country of birth | ||||
| United States | 104 (91.3) | 63 (87.5) | 41 (97.6) | 0.07 | 
| Other | 10 (8.7) | 9 (12.5) | 1 (2.4) | |
| Long-term care resident | ||||
| Yes | 7 (6.1) | 3 (4.2) | 4 (9.5) | 0.25 | 
| No | 107 (93.9) | 69 (95.8) | 38 (90.5) | |
| Homeless | ||||
| Yes | 18 (15.8) | 6 (8.3) | 12 (28.6) | 0.004 | 
| No | 96 (84.2) | 66 (91.7) | 30 (71.4) | |
| Prison resident | ||||
| Yes | 13 (11.4) | 8 (11.1) | 5 (11.9) | 0.86 | 
| No | 101 (88.6) | 64 (88.9) | 37 (88.1) | |
| Abuses alcohol | ||||
| Yes | 40 (35.0) | 19 (26.4) | 21 (50.0) | 0.01 | 
| No | 74 (65.0) | 53 (73.6) | 21 (50.0) | |
| Uses injection drugs | ||||
| Yes | 17 (14.9) | 11 (15.3) | 6 (14.3) | 0.89 | 
| No | 97 (85.1) | 61 (84.7) | 36 (85.7) | |
| Uses noninjection drugs | ||||
| Yes | 35 (30.7) | 23 (31.9) | 12 (28.6) | 0.71 | 
| No | 79 (69.3) | 49 (68.1) | 30 (71.4) | |
| HIV-infected | ||||
| Yes | 28 (24.6) | 16 (22.2) | 12 (28.6) | 0.45 | 
| No | 86 (75.4) | 56 (77.8) | 30 (71.4) | 
Page created: July 19, 2010
                            Page updated: July 19, 2010
                            Page reviewed: July 19, 2010
        
    The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
